Anticancer effect of adenosine on gastric cancer via diverse signaling pathways

Ayako Tsuchiya1, Tomoyuki Nishizaki1

  • 1Ayako Tsuchiya, Tomoyuki Nishizaki, Division of Bioinformation, Department of Physiology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan.

Insights

Extracellular adenosine triggers cancer cell death through intrinsic and extrinsic pathways. Specific mechanisms vary by gastric cancer cell type, offering potential for targeted therapies.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Oncology

Background:

  • Extracellular adenosine induces apoptosis in various cancer cells through intrinsic and extrinsic pathways.
  • Adenosine's role in gastric cancer cell apoptosis involves cellular uptake and receptor-mediated signaling.
  • Mechanisms differ based on gastric cancer cell subtypes, necessitating a nuanced understanding.

Purpose of the Study:

  • To elucidate the distinct mechanisms by which extracellular adenosine induces apoptosis in different gastric cancer cell lines.
  • To investigate the roles of adenosine transporters, adenosine kinase, AMP-activated protein kinase (AMPK), and adenosine receptors in apoptosis.
  • To identify downstream molecular targets for developing targeted gastric cancer chemotherapy.

Main Methods:

  • Analysis of adenosine uptake and intracellular conversion to AMP.
  • Assessment of AMP-activated protein kinase (AMPK) activation.
  • Investigation of adenosine receptor (A3) signaling pathways, including G protein coupling and downstream effectors like phospholipase Cγ and protein kinase C.
  • Comparative analysis of apoptosis induction in GT3-TKB, MKN28, and MKN45 gastric cancer cells.

Main Results:

  • Extracellular adenosine induces caspase-independent apoptosis in GT3-TKB cells via AMPK activation.
  • Extracellular adenosine induces caspase-dependent apoptosis in MKN28 and MKN45 cells through both AMPK-independent AMP signaling and A3 adenosine receptor activation.
  • A3 receptor signaling involves Gi/Gq proteins, phospholipase Cγ, and protein kinase C activation.

Conclusions:

  • The mechanisms of adenosine-induced apoptosis in gastric cancer are cell-type specific.
  • Distinct intracellular pathways (AMPK-dependent vs. independent) and receptor-mediated signaling contribute to apoptosis.
  • Understanding these varied molecular mechanisms is crucial for developing personalized gastric cancer chemotherapy strategies.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
752
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.2K